NCT06885034 - A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed | Biotech Hunter

Enrollment

320

Participants

Timeline

Start Date

June 11, 2025

Primary Completion Date

November 11, 2027

Study Completion Date

June 23, 2028

Conditions

Gastrointestinal Neoplasms

Interventions

BIOLOGICAL

GSK5764227

GSK5764227 will be administered

Trial Locations (12)

3000

RECRUITING

GSK Investigational Site, Melbourne

3084

RECRUITING

GSK Investigational Site, Heidelberg

78229

RECRUITING

GSK Investigational Site, San Antonio

98801

RECRUITING

GSK Investigational Site, Wenatchee

M5G 2M9

RECRUITING

GSK Investigational Site, Toronto

J1H 5N4

RECRUITING

GSK Investigational Site, Sherbrooke

060-8648

RECRUITING

GSK Investigational Site, Hokkaido

565-0871

RECRUITING

GSK Investigational Site, Osaka

135-8550

RECRUITING

GSK Investigational Site, Tokyo

110 744

RECRUITING

GSK Investigational Site, Seoul

135-710

RECRUITING

GSK Investigational Site, Seoul

138-736

RECRUITING

GSK Investigational Site, Seoul